Novo Nordisk A/S Sponsored ADR Class B is a company in the U.S. stock market and it is a holding in 7 U.S.-traded ETFs. NVO has around 1.0M shares in the U.S. ETF market. The largest ETF holder of NVO is the First Trust Value Line Dividend Index Fund (FVD), with approximately 807.41K shares. Investors may also find of interest that the ETF with the largest allocation to NVO stock is VanEck Vectors Pharmaceutical ETF (PPH), with a portfolio weight of 5.32%. On average, U.S. ETFs allocate 1.23% of NVO to their portfolios.